Curtis Triplitt
The University of Texas Health Science Center at San Antonio(US)University Health System(US)Texas Diabetes Institute(US)Group for the Analysis of Development(PE)
Publications by Year
Research Areas
Diabetes Treatment and Management, Diabetes Management and Research, Metabolism, Diabetes, and Cancer, Pancreatic function and diabetes, Pharmacology and Obesity Treatment
Most-Cited Works
- → Assessment of Pancreatic β-Cell Function: Review of Methods and Clinical Applications(2014)285 cited
- → Effect of rosiglitazone on glucose and non-esterified fatty acid metabolism in Type II diabetic patients(2001)276 cited
- → Abdominal fat distribution and peripheral and hepatic insulin resistance in type 2 diabetes mellitus(2002)256 cited
- → Initial combination therapy with metformin, pioglitazone and exenatide is more effective than sequential add‐on therapy in subjects with new‐onset diabetes. Results from the E fficacy and D urability of I nitial C ombination T herapy for T ype 2 D iabetes ( EDICT ): a randomized trial(2014)196 cited
- → Mechanism of action of exenatide to reduce postprandial hyperglycemia in type 2 diabetes(2008)157 cited
- → Drug Interactions of Medications Commonly Used in Diabetes(2006)116 cited